Alpha Tau Receives FDA's Breakthrough Device Designation for the Treatment of Recurrent GBM

JERUSALEM, Oct. 8, 2021 -- (Healthcare Sales & Marketing Network) -- Alpha Tau Medical, the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, is pleased to announce that it has received Breakthrough Device Designation for Alpha DaRT ... Devices, Oncology Alpha Tau Medical, Alpha DaRT, glioblastoma multiforme
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news